Clinical Trial

Anti-Inflammatory Diet in BRC Patients on Aromatase Inhibitors

Study acronym: AID
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 9, 2024 (before its estimated March 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This project aims to decrease undesirable side effects and increase qulaity of life of aromatase inhibitors therapy in breast cancer survivors, by anti-inflammatory diet or supplementation.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-01-10; most recent amendment 2024-05-07.
Status change: Not Yet Recruiting → Recruiting 2024-05-07
Trial Details
NCT Number NCT06214598
Lead Sponsor University of Belgrade
Conditions Breast Cancer
Enrollment 90 participants
Start Date 2024-03-01
Primary Completion 2025-03-31 (estimated)
Study Completion 2026-11-30 (estimated)
Updated on ClinicalTrials.gov 2024-05-09